Related Experiment Video
Updated: Jul 6, 2025

05:45
Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay
Published on: April 5, 2019
23.4K
Susceptibility-weighted image features in AQP4-negative-NMOSD versus MS
Chenyang Gao1, Lei Su1, Hongfang Li2
1Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, PR China.
Multiple Sclerosis and Related Disorders
|January 4, 2024
Summary
Susceptibility-weighted imaging (SWI) reveals distinct features in aquaporin 4 (AQP4)-immunoglobulin G (IgG)-negative neuromyelitis optica spectrum disorder (NMOSD). These SWI characteristics, including paramagnetic rim and nodular lesions, help differentiate NMOSD from multiple sclerosis (MS).
Area of Science:
- Neuroimaging
- Neurology
- Radiology
Background:
- Neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS) are distinct inflammatory demyelinating diseases.
- Differentiating aquaporin 4 (AQP4)-immunoglobulin G (IgG)-negative NMOSD from MS is clinically important.
- Susceptibility-weighted imaging (SWI) is sensitive to paramagnetic substances like iron and deoxhemoglobin.
Purpose of the Study:
- To characterize SWI features in AQP4-IgG-negative NMOSD, specifically paramagnetic rim and nodular lesions, and the central vein sign (CVS).
- To evaluate the utility of these SWI features as imaging biomarkers for distinguishing MS from AQP4-IgG-negative NMOSD.
Main Methods:
- Prospective recruitment of patients with AQP4-IgG-negative NMOSD, AQP4-IgG-positive NMOSD, and MS.
- Analysis of SWI features including paramagnetic rim and nodular lesions, and CVS.
- Determination of sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for distinguishing MS from AQP4-IgG-negative NMOSD.
Main Results:
- AQP4-IgG-negative NMOSD patients showed significantly fewer paramagnetic rim and nodular lesions on SWI compared to MS patients.
- The rate of central vein sign (CVS) positivity was lower in AQP4-IgG-negative NMOSD (12%) than in MS (46%).
- SWI features (paramagnetic rim/nodular lesions) demonstrated high sensitivity (90.4%) and specificity (95.5%) for differentiating MS from AQP4-IgG-negative NMOSD.
Conclusions:
- SWI features, including paramagnetic rim or nodular hypointense signals and the presence of ≥3 CVS lesions, are valuable in distinguishing MS from AQP4-IgG-negative NMOSD.
- These SWI findings suggest potential as imaging biomarkers for differential diagnosis in neuroinflammatory diseases.

